Similarly, in a melanoma model, B16 tumours-derived Tregs were able to suppress CTL-mediated killing of explanted tumour cells, with restoration by neutralising antibodies against TGFβ on the Tregs [167]. The gene discussed is TGFB1; the disease is neoplasm.